Stockscreener 앱 받기
37.52
2.21%
0.81
Harmony Biosciences Holdings Inc 주식(HRMY)의 최신 뉴스
What drives Harmony Biosciences Holdings Inc. stock priceOutstanding growth strategies - Autocar Professional
Is Harmony Biosciences Holdings Inc. a good long term investmentSkyrocketing investment returns - Autocar Professional
How high can Harmony Biosciences Holdings Inc. stock price go in 2025Free Stock Market Query - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - MarketScreener
Harmony Biosciences Advances Pipeline While Navigating Analyst Caution - Insider Monkey
Harmony Biosciences Holdings Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
What analysts say about Harmony Biosciences Holdings Inc. stockBreakout profit opportunities - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Resu - GuruFocus
13 Best Low Risk High Growth Stocks to Buy - Insider Monkey
Truist Securities initiates Harmony Biosciences stock with Buy rating By Investing.com - Investing.com Nigeria
Truist Securities Initiates Coverage on Harmony Biosciences (HRM - GuruFocus
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock - Investing.com
Truist Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Truist Initiates Buy Rating for Harmony Biosciences (HRMY) with Promising Growth Prospects | HRMY Stock News - GuruFocus
Why Harmony Biosciences Holdings Inc. stock attracts strong analyst attentionFree Access to Investment Community - beatles.ru
Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again - MSN
Transcript : Harmony Biosciences Holdings, Inc. Presents at H.C. Wainwright "HCW@Home" Series, Jul-17-2025 10 - MarketScreener España
Harmony Biosciences Balances Growth Potential With Clinical Milestones - Finimize
Harmony Biosciences to Participate in H.C. Wainwright HCW@Home Series - MarketScreener
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
Mizuho Reaffirms “Outperform” on Harmony Biosciences (HRMY) for BP1.15205 Data - MSN
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series - BioSpace
3 Reasons Growth Investors Will Love Harmony Biosciences (HRMY) - Yahoo Finance
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? - Yahoo Finance
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect? - Zacks Investment Research
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series | HRMY Stock News - GuruFocus
Harmony Biosciences CEO to Share Latest Company Updates at Exclusive H.C. Wainwright Virtual Conference - Stock Titan
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY) - ACCESS Newswire
Most Volatile Stocks in the US (July 2025) - Investing.com
Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN
Harmony Biosciences Preclinical Data for Narcolepsy Drug BP1.15205 Shows Promise - MSN
Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating - Investing.com Canada
Goldman Sachs Resumes Harmony Biosciences Holdings Inc. (HRMY) at Neutral - StreetInsider
0.97%
0.22%
자본화:
|
볼륨(24시간):